GSK3B and head and neck squamous cell carcinoma: In our study, we delved into the effects of ACTN1 overexpression on GSK-3β, revealing that ACTN1 negatively impacts GSK-3β stability in HNSCC cells and expedites its degradation via the ubiquitin–proteasome pathway.